Malignant Head and Neck Neoplasm — Trials

Malignant Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,448 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,431
Recruiting: 781
Ph III recruiting: 109
Growth YoY: +20.1%
Industry share: 18%
Top sponsor: Sun Yat-sen University
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (629)

clinicaltrialsPublishedShowing 251–300 of 5,448 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06305247	A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours	active not recruiting	Phase 1 / Phase 2	36	IpsenINDUSTRY	3	Sep 1, 2026	clinicaltrials
NCT06568172	Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer	suspended	Phase 3	420	National Cancer Institute (NCI)NIH	3	Sep 1, 2026	clinicaltrials